채용
岗位职责：
- 参与生化分析仪器新设备安装调试、验证工作，能按照文件正确维护和保养仪器；
- 参与生化分析方法优化、转移、验证工作；
- 协助日常生化测试工作，测试包含但不局限于结合活性，HCP，Protein A和DNA等；
- 协助产品的稳定性研究测试；
- 根据SOP完成测试，保证实验过程和结果的及时性和准确性；
- 协助生化实验室试剂耗材的管理和维持现场6S；
- 严格遵守公司EHS安全法规，掌握安全工作技能和应急救援知识；
- 保持QC实验室的高GMP合规性和DI；
- 配合生化主管完成实验室发生的偏差、OOS/OOE/OOT等的调查，严格按照CAPA要求实施；
- 协助部门按时完成项目进度。
任职要求：
- 本科及以上学历，生物、化学、药学或其他相关理工科专业；
- 具备良好的职业素养和团队协助能力；
- 熟练使用各种办公软件。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
Engineer, FEA
Trane Technologies · Shanghai, Shanghai, China
Regional Division Applications Engineer
KLA · Shanghai, China
Manufacturing Engineer
Emerson · Shanghai, Shanghai, China, CN
Thermal Fluid Testing Engineer
BP · China - Shanghai
ALKO Site Engineering Leader
Trane Technologies · Taicang, Jiangsu, China
BioNTech 소개
BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago